Berger, J. & Hinglais, N. [Intercapillary deposits of IgA-IgG]. J. Urol. Nephrol. 74, 694–695 (1968).

CAS  Google Scholar 

McGrogan, A., Franssen, C. F. M. & De Vries, C. S. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol. Dial. Transpl. 26, 414–430 (2011).

Article  Google Scholar 

Schena, F. P. & Nistor, I. Epidemiology of IgA nephropathy: a global perspective. Semin. Nephrol. 38, 435–442 (2018).

Article  PubMed  Google Scholar 

Knoppova, B. et al. Pathogenesis of IgA nephropathy: current understanding and implications for development of disease-specific treatment. J. Clin. Med. 10, 4501 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pillebout, E. IgA vasculitis and IgA nephropathy: same disease? J. Clin. Med. 10, 2310 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willey, C. J. et al. The incidence and prevalence of IgA nephropathy in Europe. Nephrol. Dial. Transpl. 38, 2340–2349 (2023).

Article  Google Scholar 

Barbour, S. J. et al. Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease. Kidney Int. 84, 1017–1024 (2013).

Article  CAS  PubMed  Google Scholar 

D’Amico, G. & D’Amico, G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin. Nephrol. 24, 179–196 (2004).

Article  PubMed  Google Scholar 

Pitcher, D. et al. Long-term outcomes in IgA nephropathy. Clin. J. Am. Soc. Nephrol. 18, 727–738 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Floege, J. Recurrent IgA nephropathy after renal transplantation. Semin. Nephrol. 24, 287–291 (2004).

Article  PubMed  Google Scholar 

Jarrick, S. et al. Mortality in IgA nephropathy: a nationwide population-based cohort study. J. Am. Soc. Nephrol. 30, 866–876 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Hastings, M. C. et al. Life expectancy for patients from the Southeastern United States with IgA nephropathy. Kidney Int. Rep. 3, 99–104 (2018).

Article  PubMed  Google Scholar 

Barbour, S. J. et al. Updating the international IgA nephropathy prediction tool for use in children. Kidney Int. 99, 1439–1450 (2021).

Article  CAS  PubMed  Google Scholar 

Suzuki, H. et al. The pathophysiology of IgA nephropathy. J. Am. Soc. Nephrol. 22, 1795–1803 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scionti, K., Molyneux, K., Selvaskandan, H., Barratt, J. & Cheung, C. K. New insights into the pathogenesis and treatment strategies in IgA nephropathy. Glomerular Dis. 2, 15–29 (2022).

Article  PubMed  Google Scholar 

Allen, A. C. et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int. 60, 969–973 (2001).

Article  CAS  PubMed  Google Scholar 

Allen, A. C., Bailey, E. M., Barratt, J., Buck, K. S. & Feehally, J. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J. Am. Soc. Nephrol. 10, 1763–1771 (1999).

Article  CAS  PubMed  Google Scholar 

Hiki, Y. et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 59, 1077–1085 (2001).

Article  CAS  PubMed  Google Scholar 

Coppo, R. & Amore, A. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int. 65, 1544–1547 (2004).

Article  CAS  PubMed  Google Scholar 

Xu, L. X. & Zhao, M. H. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int. 68, 167–172 (2005).

Article  CAS  PubMed  Google Scholar 

Gharavi, A. G. et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J. Am. Soc. Nephrol. 19, 1008–1014 (2008).

Article  PubMed  PubMed Central  Google Scholar 

Tomana, M. et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 52, 509–516 (1997).

Article  CAS  PubMed  Google Scholar 

Tomana, M. et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104, 73–81 (1999).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Knoppova, B. et al. The origin and activities of IgA1-containing immune complexes in IgA nephropathy. Front. Immunol. 7, 117 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Cheung, C. K., Dormer, J. P. & Barratt, J. The role of complement in glomerulonephritis — are novel therapies ready for prime time? Nephrol. Dial. Transpl. 38, 1789–1797 (2022).

Article  Google Scholar 

Kerr, M. A. The structure and function of human IgA. Biochem. J. 271, 285–296 (1990).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barratt, J. et al. Why target the gut to treat IgA nephropathy? Kidney Int. Rep. 5, 1620–1624 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Perše, M. & Večerić-Haler, Ž. The role of IgA in the pathogenesis of IgA nephropathy. Int. J. Mol. Sci. 20, 6199 (2019).

Article  PubMed  PubMed Central  Google Scholar 

He, J.-W. et al. Associations of genetic variants contributing to gut microbiota composition in immunoglobin a nephropathy. mSystems 6, e00819–e00820 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao, J. et al. Expansion of Escherichia-Shigella in gut is associated with the onset and response to immunosuppressive therapy of IgA nephropathy. J. Am. Soc. Nephrol. 33, 2276–2292 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lebreton, C. et al. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology 143, 698–707.e4 (2012).

Article  CAS  PubMed  Google Scholar 

Matysiak-Budnik, T. et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J. Exp. Med. 205, 143–154 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Woof, J. M. & Russell, M. W. Structure and function relationships in IgA. Mucosal Immunol. 4, 590–597 (2011).

Article  CAS